-
Innovation Ranking
New![]()
Innovation Ranking – Harrow Health Inc
Harrow Health Inc (Harrow Health) formerly known as Imprimis Pharmaceuticals Inc, owns a portfolio of healthcare businesses which also includes ImprimisRx, the ophthalmology pharmaceutical compounding business in the US and holds large equity positions in Eton Pharmaceuticals, Melt Pharmaceuticals and Surface Pharmaceuticals. The company is focused on developing innovative medications to serve ophthalmology industry in the marketplace. The company through its subsidiaries develops injectable Dropless Therapy formulations and topical LessDrops formulations. MAY-44 for treating dyspareunia and MAY-88 for treating interstitial...
-
Company Profile
![]()
Harrow Health Inc – Company Profile
Harrow Inc (Harrow Health) formerly known as Harrow Health Inc, owns a portfolio of healthcare businesses which also includes ImprimisRx, the ophthalmology pharmaceutical compounding business in the US and holds large equity positions in Eton Pharmaceuticals, Melt Pharmaceuticals and Surface Pharmaceuticals. The company is focused on developing innovative medications to serve ophthalmology industry in the marketplace. The company through its subsidiaries develops injectable Dropless Therapy formulations and topical LessDrops formulations. MAY-44 for treating dyspareunia and MAY-88 for treating interstitial cystitis...
Add to Basket -
Product Insights
![]()
Cataract Disease – Global Clinical Trials Review, H1 2020
GlobalData's clinical trial report, “Cataract Global Clinical Trials Review, H1, 2020" provides an overview of Cataract Clinical trials scenario. This report provides top line data relating to the clinical trials on Cataract. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.